[Nicotine dependence--medico-biological aspects]
- PMID: 11894603
[Nicotine dependence--medico-biological aspects]
Abstract
The nicotine in tobacco products is strongly addictive. This was generally recognised no earlier than in the late 1970s, though it was well known within the international tobacco industry in the early 1960s. Nicotine acts as an addictive substance by binding to acetylcholine receptors and causing the release of dopamine in the brain, though other signalling substances are also important for the action of nicotine in the central nervous system. Withdrawal syndrome is the typical evidence of physical addiction to nicotine. Nicotine addiction can develop rapidly. There are, however, individual differences; genetic predisposition may have a bearing on these differences.
Similar articles
-
New mechanisms and perspectives in nicotine withdrawal.Neuropharmacology. 2015 Sep;96(Pt B):223-34. doi: 10.1016/j.neuropharm.2014.11.009. Epub 2014 Nov 26. Neuropharmacology. 2015. PMID: 25433149 Free PMC article. Review.
-
Nicotinic receptors and stages of nicotine dependence.J Psychopharmacol. 2010 Jun;24(6):793-808. doi: 10.1177/0269881108100256. Epub 2009 Feb 27. J Psychopharmacol. 2010. PMID: 19251827 Review.
-
Double target concept for smoking cessation.Acta Pharmacol Sin. 2010 Sep;31(9):1015-8. doi: 10.1038/aps.2010.137. Epub 2010 Aug 16. Acta Pharmacol Sin. 2010. PMID: 20711220 Free PMC article.
-
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.Clin Pharmacol Ther. 2008 Apr;83(4):531-41. doi: 10.1038/clpt.2008.3. Epub 2008 Feb 27. Clin Pharmacol Ther. 2008. PMID: 18305452 Review.
-
Chronic nicotine and withdrawal affect glutamatergic but not nicotinic receptor expression in the mesocorticolimbic pathway in a region-specific manner.Pharmacol Res. 2016 Jan;103:167-76. doi: 10.1016/j.phrs.2015.11.016. Epub 2015 Nov 26. Pharmacol Res. 2016. PMID: 26631628